Differential Diagnosis between Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
Explore this paper's citation graph
Summary
Clinically relevant guidance for diagnosing and differentiating between NMOSD and MS is focused on.
- Type
- article
- Published
- 2016-11-01
- Cited by
- 2
- References
- 53
- OpenAlex
- https://openalex.org/W2548732625
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:79422651
Keywords
Neuromyelitis optica, Multiple sclerosis, Spectrum disorder, Medicine, Aquaporin 4
References
- Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum
- Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later
- Low Myo‐inositol indicating astrocytic damage in a case series of neuromyelitis optica
- Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder
- The epidemiology of multiple sclerosis in Europe
- Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
- Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder
- Oligoclonal bands in Devic’s neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations
- Demographic and clinical features of neuromyelitis optica: A review
- Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status
- Preferential spinal central gray matter involvement in neuromyelitis optica
- The genetic epidemiology of multiple sclerosis.
- Distinguishing Optic Neuritis in Neuromyelitis Optica Spectrum Disease From Multiple Sclerosis: A Novel Magnetic Resonance Imaging Scoring System
- Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies
- Bright spotty lesions on the spinal cord: an additional MRI indicator of neuromyelitis optica spectrum disorder?
- Venocentric Lesions: An MRI Marker of MS?
- Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
- Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution
- The clinical course of neuromyelitis optica (Devic’s syndrome)
- Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis
Cited by
Related papers
- The proteome profile of the urine is different in patients with neuromyelitis optica compared to multiple sclerosis and healthy subjects
- Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
- Sudden Onset Of Sleep Due To Bilateral Hypothalamic Lesions In Neuromyelitis Optica Spectrum Disorder Positive For Aquaporin 4 Antibody (AQP4) (P5.298)
- Aquaporin-4–neuromyelitis optica spectrum disorder is not a progressive disease
- Benefit of eculizumab for a broad range of patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: findings from prevent
- Aquaporin-4 neuromyelitis optica spectrum disorder in a 2-year-old girl: Diagnostic and treatment considerations.
- Myelitis with Aquaporin-4 autoantibody in a patient with Sjogren´s syndrome: Neurological Manifestation or coexistence of Neuromyelitis Optica Spectrum Disorder?
- Treatment De-escalation in AQP4-Ab Neuromyelitis Optica Spectrum Disorder
- SAkuraBONSAI: A Prospective, Open-label Study of Satralizumab Investigating Novel Imaging, Biomarker, and Clinical Outcomes in Patients with Aquaporin-4-IgG-seropositive (P15.AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD) (P15-1.002)